Laboratorios Roemmers S.A.I.C.F. Report issue

For profit Phase 4
Founded: Roemp Argentina (1921)

Organization Overview

First Clinical Trial
2020
NCT04463264
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Laboratorios Roemmers S.A.I.C.F.

Active Ingredients

Drugs in Phase 4 Trials (1)

nitazoxanide (Alinia) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infections (Phase 3)

Virus Diseases (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 1